Arizona Oncology Welcomes Gynecologic Oncologist Jillian Oâ€™Donnell MD, to Tucson â€“ Orange Grove Location
By Christina Caldwell -
Monday Dec 05, 2022
Arizona Oncology, a premier provider of advanced cancer care across Arizona, is proud to welcome Jillian Oâ€™Donnell, MD, to its gynecologic oncology team. She joins a compassionate team providing expert care to patients in the Tucson area. Dr. Oâ€™Donnell will see patients at Arizona Oncologyâ€™s Tucson â€“ Orange Grove location.
Jillian Oâ€™Donnell, MD earned her medical degree from McGovern Medical School before completing her residency in obstetrics and gynecology at the University of Alabama at Birmingham. She also completed her gynecologic oncology fellowship at the University of North Carolina at Chapel Hill. She is board certified in obstetrics and gynecology. In December 2020, she was invited to speak for the International Gynecologic Cancer Society Project ECHO Virtual Tumor Board in Danang, Vietnam, presenting â€œBRCA Mutations for the Gynecologic Oncologist.â€ She presented â€œSurgical Management of Vulvar Cancerâ€ to the same group in June 2021. Dr. Oâ€™Donnell is a current member of the American College of Obstetricians and Gynecologists, the American Society of Clinical Oncology, and the Society of Gynecologic Oncology.
â€œDr. Oâ€™Donnell is a highly-skilled physician who is committed to contributing to the field of gynecologic oncology,â€ said Joseph Buscema, MD. â€œShe has a patient-centric approach to treatment that aligns strongly with our mission to provide personalized cancer care.â€
Dr. Oâ€™Donnell treats gynecological cancers, including ovarian, uterine, cervical, vaginal, vulvar, and other cancers of the female reproductive tract. She specializes in the comprehensive surgical management of gynecological cancers, including both open and minimally invasive or robotic surgeries. She is passionate about providing comprehensive care, starting with the initial diagnosis and treatment through surgery, medical management, and supportive care.
â€œI became a physician for the opportunity to interact with, learn from, and serve others,â€ said Dr. Oâ€™Donnell. â€œI am thrilled to serve patients at Arizona Oncology, where we can provide access to the best and latest technologies in a convenient and accessible community setting.â€
The Tucson â€“ Orange Grove office is located at 1845 W. Orange Grove Rd., Bldg. 2, Tucson, AZ, 85704. To schedule an appointment, call 520-531-8967 or visit http://www.arizonaoncology.com.
About Arizona Oncology
Arizona Oncology is one of the largest medical groups in Arizona, with more than 50 physicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. Since its inception in 1998, Arizona Oncology has led with the philosophy that itâ€™s beneficial to provide cancer therapies in a community setting, close to patients' homes and support systems. Arizona Oncology specializes in Medical, Gynecologic, and Radiation Oncology, Hematology, Breast Surgery, Colorectal Surgery, Urology, Research, Genetic Risk Assessment, and patient ancillary programs. The physicians and their staff treat patients in many communities throughout the state including Glendale, Goodyear, Green Valley, Oro Valley, Phoenix, Prescott, Prescott Valley, Scottsdale, and Tucson. For more information, visit http://www.arizonaoncology.com.
Arizona Oncology is an affiliate of The US Oncology Network (The Network). This collaboration unites AO with more than 1,400 independent physicians dedicated to delivering value-based, integrated care for patients â€” close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The US Oncology Network is supported by McKesson Specialty Health, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. AO also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.